William Werbel MD PhD

Transplant/Oncology Infectious Diseases @JHMed_ID; Epi/Quant @Hopkins_TRC. Advancing intersection of HIV & transplantation, studying 💉 vs viruses. Views=me

[William Werbel MD PhD @HIV_TID]

The Emerging Pathogens of Concern (EPOC) research study (IRB0038184; Principal Investigator Dr. William Werbel) is live, studying infections & vaccines in immunocompromised persons & close contacts. Visit https://t.co/Rr0QLSY9ky or email [email protected] for more info!

[Johns Hopkins Division of Infectious Diseases @JHMed_ID]

Congratulations to Dr. Christine Durand, recently elected to the American Society of Clinical Investigation! Her work on solid organ transplantation has changed policy and the lives of patients. 😎

[DrDemetre @dr_demetre]

US CDC: a public health agency in critical condition - The Lancet https://t.co/ULXj9xLmmS

[Landsberg Society @Landsberg_Soc]

Registration is OFFICIALLY open! 🥳

https://t.co/I1NxHhFzdV

[Gilead Sciences @GileadSciences]

#GileadNews: The FDA has approved our injectable HIV-1 prevention medication, making it the first and only twice-yearly #HIV prevention option in the U.S. This approval is helping to usher in the future of prevention as we work to help end the epidemic. https://t.co/wGacaduPRn

[Camille Nelson Kotton @KottonNelson]

Very proud of the 17 dismissed ACIP members for writing this together – Advisory Committee on Immunization Practices at a Crossroads | JAMA | JAMA Network https://t.co/2vYkYKEF5I

[Andrew Pekosz @andrewpekosz]

A bill to dissolve NIAID has been introduced in Congress. Start contacting your US legislators now!

https://t.co/YZX50LMkUK

[JAMA @JAMA_current]

Sanjat Kanjilal of Harvard Medical School joins JAMA Associate Editor Yulin Hswen to discuss the use of machine learning algorithms to assess the management of urinary tract infection and more.

https://t.co/Gdlq5wEK1M

[Farzad Mostashari @Farzad_MD]

1/ After residency at Mass General Hospital, I reported to Atlanta to meet my fellow CDC Epidemic Intelligence Service Officers.

I have never felt so intimidated by my peers

The best and the brightest, they were star clinicians, had served in disaster zones; MD/PhDs and MSF.

[William Werbel MD PhD @HIV_TID]

@victoriahall26 @NEJM @PeterMacCC @NCICancer Congrats, Tori!

[William Werbel MD PhD @HIV_TID]

@MichaelGIsonMD @JAMA_current @Hopkins_TRC @AndrewKaraba @Dorry_Segev Thanks, Mike!

[William Werbel MD PhD @HIV_TID]

Ringing in 2025 with our work evaluating antibody response to RSV vaccines in immunocompromised persons in @JAMA_current (Editor's choice!). A preliminary product of our ongoing EPOC study (https://t.co/Rr0QLSYHa6)
https://t.co/EstJukWJKM @Hopkins_TRC @AndrewKaraba @Dorry_Segev

[IDSA @IDSAInfo]

New #LetsTalkID episode out now!

Medical editors of the Real-Time Learning Network (@MatiH_ID, @Payal_Patel, @mariasundaram, @HIV_TID) recount their experiences building the project and discuss lessons learned for the future.

Transcript: https://t.co/gSgMfGv41H

[Hopkins Med News @HopkinsMedNews]

Study in @NEJM (https://t.co/Et5aTNsBuL) led by @HopkinsMedicine provides strong evidence that #HIV-to-HIV transplants are as safe & effective as transplants using organs from donors w/o HIV. See https://t.co/OnkQjk1EVF. @HopkinsTRC @hopkinssurgery @JHMed_ID #ChristineDurandMD

[Michael Ison, MD MS @MichaelGIsonMD]

🚨 CRITICAL READ 🚨

If you do research in Transplant ID, this paper is a MUST read. From @CMDurandMD and the @Hopkins_TRC a brilliant blueprint in how to build a successful transplant research center. From @TheTxIDjournal

https://t.co/YeuuBxqlkO

[William Werbel MD PhD @HIV_TID]

🫡

[Mati Hlatshwayo Davis, MD, MPH, FIDSA @MatiH_ID]

Coming to the end of an era after almost 4 years with the editorial board of the COVID-19 Real Time Learning Network @RealTimeCOVID19. As the grant comes to an end we came together to record a podcast for this incredible resource we built: dropping soon! https://t.co/kGS6hLHjpe

[William Werbel MD PhD @HIV_TID]

@Hopkins_TRC

[William Werbel MD PhD @HIV_TID]

Thank you for featuring this insightful work led by @MayanTeles @ Janetta Brundage.

[Healio Rheumatology @HealioRheum]

➡️ 29.8% of patients with systemic autoimmune diseases reported long #COVID 12 or more weeks after infection, new data shows #medtwitter #rheumtwitter

Healio has the rundown, with input from co-author @HIV_TID 👇

https://t.co/wmb0D4E1rL

[AASLD Foundation @AASLDFoundation]

Introducing the 2024 Pilot Research Awardees! 🤩 Huge congrats to Patricia Bloom, MD.
Learn more about AASLD Foundation's 2024 awardees at https://t.co/vVOwKF3Nyt

[William Werbel MD PhD @HIV_TID]

Definitionally re: reinfections, 1st had to have occurred earlier (in less immune state), ? complicated by persistent or later "exacerbatable" sequelae. Also ? link between heavier immunosuppression and reinfection risk post vaccination. Regardless, data support 💉 in this group.

[William Werbel MD PhD @HIV_TID]

Great work @MayanTeles @janettabrundage @TeresaChiangMD in assessing post-acute COVID aka #longcovid prevalence, syndromes, and risk factors in persons with autoimmune/rheumatic conditions leveraging our national prospective cohort. https://t.co/62C0WjNxfE @JHMed_ID @Hopkins_TRC

[William Werbel MD PhD @HIV_TID]

≥1 symptom reported by 30%, widely varying phenotypes (subgroup with symptoms in all 5 domains). This was following mild infections, majority post vaccination in Omicron era. Pre-infxn vaccination appeared protective! Whereas reinfections might be risk for #PASC.